Corgi Genomics & Precision Medicine ETF
Corgi Genomics & Precision Medicine ETF reported 58 holdings worth US$1.71M as of Jun 30, 2026 (Form N-PORT)
As of Jun 30, 2026 · Filed Sep 1, 2026
Corgi Genomics & Precision Medicine ETF reported 58 holdings worth US$1.71M as of Jun 30, 2026. Largest: Thermo Fisher Scientific Inc, Vertex Pharmaceuticals Incorporated and Alnylam Pharmaceuticals, Inc. Filed Sep 1, 2026 (Form N-PORT).
- Holdings
- 58
- Value as reported
- US$1.71M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Thermo Fisher Scientific Inc | 264 | US$132K | 7.7% |
| Vertex Pharmaceuticals Incorporated | 231 | US$115K | 6.7% |
| Alnylam Pharmaceuticals, Inc. | 220 | US$66,227 | 3.9% |
| Guardant Health, Inc. | 429 | US$64,363 | 3.8% |
| Moderna, Inc. | 913 | US$63,937 | 3.7% |
| Revolution Medicines, Inc. | 341 | US$63,862 | 3.7% |
| Illumina, Inc. | 363 | US$63,826 | 3.7% |
| Incyte Corporation | 462 | US$52,372 | 3.1% |
| Genmab A/s | 168 | US$45,930 | 2.7% |
| Bio-techne Corp | 605 | US$42,743 | 2.5% |
| Ionis Pharmaceuticals, Inc. | 528 | US$41,865 | 2.4% |
| Krystal Biotech, Inc. | 110 | US$40,884 | 2.4% |
| Biomarin Pharmaceutical Inc. | 693 | US$39,653 | 2.3% |
| Arrowhead Pharmaceuticals, Inc. | 451 | US$36,761 | 2.2% |
| Twist Bioscience Corporation | 341 | US$35,082 | 2.1% |
| Uniqure N.v. | 748 | US$34,453 | 2.0% |
| Veracyte, Inc. | 583 | US$34,240 | 2.0% |
| 10x Genomics, Inc. | 891 | US$34,161 | 2.0% |
| Qiagen N.v. | 858 | US$33,548 | 2.0% |
| Nuvalent, Inc. | 264 | US$32,604 | 1.9% |
| Tempus Ai, Inc. | 517 | US$29,950 | 1.8% |
| Crispr Therapeutics Ag | 517 | US$28,197 | 1.6% |
| Adaptive Biotechnologies Corporation | 1,298 | US$27,842 | 1.6% |
| Absci Corporation | 2,387 | US$27,665 | 1.6% |
| Ideaya Biosciences, Inc. | 682 | US$25,418 | 1.5% |
| Ultragenyx Pharmaceutical Inc. | 748 | US$24,976 | 1.5% |
| Beam Therapeutics Inc. | 704 | US$24,161 | 1.4% |
| Nurix Therapeutics, Inc. | 990 | US$24,017 | 1.4% |
| Neogenomics, Inc. | 1,606 | US$23,432 | 1.4% |
| Grail, Inc. | 330 | US$22,529 | 1.3% |
| Personalis, Inc. | 1,562 | US$20,931 | 1.2% |
| Relay Therapeutics, Inc. | 1,111 | US$20,787 | 1.2% |
| Intellia Therapeutics, Inc. | 1,177 | US$19,915 | 1.2% |
| Iovance Biotherapeutics, Inc. | 4,477 | US$18,624 | 1.1% |
| Recursion Pharmaceuticals, Inc. | 4,664 | US$17,117 | 1.0% |
| Caredx, Inc. | 594 | US$16,929 | 0.99% |
| Sarepta Therapeutics, Inc. | 924 | US$16,604 | 0.97% |
| Schrodinger, Inc. | 1,001 | US$16,266 | 0.95% |
| Caris Life Sciences, Inc. | 880 | US$15,682 | 0.92% |
| Generate Biomedicines, Inc. | 924 | US$15,588 | 0.91% |
| Genedx Holdings Corp. | 220 | US$15,103 | 0.88% |
| Solid Biosciences Inc. | 1,397 | US$13,956 | 0.82% |
| 4d Molecular Therapeutics, Inc. | 1,045 | US$13,899 | 0.81% |
| Azenta, Inc. | 495 | US$12,632 | 0.74% |
| Certara, Inc. | 1,815 | US$11,888 | 0.70% |
| Castle Biosciences, Inc. | 462 | US$11,019 | 0.64% |
| Myriad Genetics, Inc. | 1,925 | US$10,992 | 0.64% |
| Fulgent Genetics, Inc. | 517 | US$10,609 | 0.62% |
| Biodesix, Inc. | 462 | US$10,418 | 0.61% |
| Pacific Biosciences Of California, Inc. | 5,852 | US$9,831 | 0.58% |
| Sophia Genetics Sa | 1,551 | US$8,949 | 0.52% |
| Prime Medicine, Inc. | 2,387 | US$8,808 | 0.52% |
| Editas Medicine, Inc. | 2,574 | US$8,340 | 0.49% |
| Rocket Pharmaceuticals, Inc. | 2,343 | US$8,013 | 0.47% |
| Standard Biotools Inc. | 8,547 | US$7,032 | 0.41% |
| Precision Biosciences, Inc. | 825 | US$6,485 | 0.38% |
| Caribou Biosciences, Inc. | 3,058 | US$5,382 | 0.31% |
| Arcturus Therapeutics Holdings Inc. | 792 | US$5,322 | 0.31% |
Source
View original at SEC
Related